title: Hypotensive response to atrial natriuretic peptide administration is enhanced with age.
abstract: BACKGROUND
  Plasma levels of atrial natriuretic peptide (ANP) increase with age. To test the hypothesis that the cardiovascular response to ANP is age dependent and to examine the role of the increased levels of ANP in the hypotensive response to orthostatic challenge, we compared the hemodynamic response of young and elderly subjects to ANP infusion and orthostatic challenge.
  
  
  METHODS
  Blood pressure, heart rate, forearm cutaneous resistance, plasma ANP, and plasma norepinephrine were measured in the supine position and following upright tilt before and after a 60-minute infusion of atrial natriuretic peptide (0.05 microgram/kg/min) in 7 young (27 +/- 4 years) and 5 elderly (74 +/- 4 years) normotensive, healthy subjects.
  
  
  RESULTS
  Prior to ANP infusion, the response to upright tilt was similar in both groups. Infusion of ANP produced similar steady state plasma levels of ANP in both groups (young: 435 +/- 49 pg/ml; elderly: 429 +/- 32 pg/ml). Supine systolic blood pressure decreased by 4 +/- 2 mmHg in the young subjects and by 18 +/- 8 mmHg in the elderly subjects after infusion (p < .08). In contrast, changes in supine heart rate, forearm cutaneous resistance, and plasma norepinephrine were similar in both groups (delta heart rate: young +5 +/- 3 beats/min, elderly +4 +/- 2 beats/min; delta forearm cutaneous resistance: young -38 +/- 9%, elderly -40 +/- 6%; delta norepinephrine: young +55 +/- 11%, elderly: +43 +/- 13%). ANP infusion abolished the vasoconstrictor response normally associated with orthostatic challenge in both groups, despite a significant release of catecholemines and an enhanced heart rate response. This resulted in significant systolic blood pressure reduction in both young (-7 +/- 2 mmHg, p < .05) and elderly subjects (-16 +/- 4 mmHg, p < .05). The drop in systolic blood pressure in response to upright tilt and ANP infusion was four times larger in the elderly subjects (change from pre-ANP level: young -8 +/- 3 mmHg, elderly -32 +/- 5 mmHg, p < .005).
authors.affiliation: Charles A. Dana Research Institute, Boston, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Hausdorff
authors.forename: B A
authors.initials: BA
authors.lastname: Clark
authors.forename: R P
authors.initials: RP
authors.lastname: Shannon
authors.forename: D
authors.initials: D
authors.lastname: Elahi
authors.forename: J Y
authors.initials: JY
authors.lastname: Wei
mesh_terms: D000328:Adult; D000368:Aged; D000375:Aging / Q000502:physiology*; D009320:Atrial Natriuretic Factor / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007024:Hypotension, Orthostatic / Q000503:physiopathology*; D009638:Norepinephrine / Q000097:blood; D012867:Skin / Q000098:blood supply; D014655:Vascular Resistance / Q000187:drug effects
chemical_list: D009320:Atrial Natriuretic Factor; D009638:Norepinephrine